Refresh

Surya Pharmaceuticals Ltd. - Research Center

532516 SURYAPHARM Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10
Income

Operating income

12.64 60.33 1,622.95 1,600.42 1,141.66
Expenses

Material consumed

627.45 182.90 1,661.51 1,235.05 888.41

Manufacturing expenses

- 4.93 31.72 36.84 23.85

Personnel expenses

1.96 8.85 40.91 40.36 28.94

Selling expenses

- - - - 15.80

Adminstrative expenses

17.73 20.64 43.59 34.80 13.48

Expenses capitalised

- - - - -

Cost of sales

647.14 217.32 1,777.73 1,347.05 970.47

Operating profit

-634.51 -156.98 -154.78 253.37 171.18

Other recurring income

0.47 -17.64 -37.98 2.67 0.31

Adjusted PBDIT

-634.04 -174.62 -192.76 256.04 171.49

Financial expenses

254.79 203.69 165.85 97.78 62.53

Depreciation

62.63 62.47 34.62 26.55 20.55

Other write offs

- - - - 0.60

Adjusted PBT

-951.45 -440.78 -393.22 131.72 87.81

Tax charges

-443.85 -156.90 -120.72 31.56 14.40

Adjusted PAT

-507.60 -283.88 -272.50 100.16 73.41

Non recurring items

-219.17 -17.93 - - 2.65

Other non cash adjustments

- - - - -0.52

Reported net profit

-726.77 -301.81 -272.50 100.16 75.54

Earnigs before appropriation

-726.77 -233.79 68.67 345.67 75.54

Equity dividend

- - - - 1.88

Preference dividend

- - - - -

Dividend tax

- - - - 0.30

Retained earnings

-726.77 -233.79 68.67 345.67 73.37
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com